Zhao Feng, Wang Ping, Jiao Yuanyuan, Zhang Xiaoxiao, Chen Daquan, Xu Haiyu
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Front Pharmacol. 2020 Dec 11;11:579332. doi: 10.3389/fphar.2020.579332. eCollection 2020.
Hydroxysafflower yellow A (HSYA), as a principal natural ingredient extracted from safflower ( L.), has significant pharmacological activities, such as antioxidant, anti-inflammatory, anticoagulant, and anticancer effects. However, chemical instability and low bioavailability have been severely hampering the clinical applications of HSYA during the treatment of cardiovascular and cerebrovascular disease. Therefore, this present review systematically summarized the materials about HSYA, including acquisition methods, extraction and detection methods, pharmacokinetics, pharmacological effects and molecular mechanism, especially focus on the possible causes and resolutions about the chemical instability and low bioavailability of HSYA, in order to provide relatively comprehensive basic data for the related research of HSYA.
羟基红花黄色素A(HSYA)是从红花中提取的主要天然成分,具有显著的药理活性,如抗氧化、抗炎、抗凝和抗癌作用。然而,化学不稳定性和低生物利用度严重阻碍了HSYA在心血管和脑血管疾病治疗中的临床应用。因此,本综述系统总结了关于HSYA的资料,包括获取方法、提取和检测方法、药代动力学、药理作用和分子机制,特别关注HSYA化学不稳定性和低生物利用度的可能原因及解决方法,以便为HSYA的相关研究提供较为全面的基础数据。